Cargando…
TP53 Status and Response to Treatment in Breast Cancers
The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is r...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114547/ https://www.ncbi.nlm.nih.gov/pubmed/21760703 http://dx.doi.org/10.1155/2011/284584 |
_version_ | 1782206080204406784 |
---|---|
author | Varna, Mariana Bousquet, Guilhem Plassa, Louis-François Bertheau, Philippe Janin, Anne |
author_facet | Varna, Mariana Bousquet, Guilhem Plassa, Louis-François Bertheau, Philippe Janin, Anne |
author_sort | Varna, Mariana |
collection | PubMed |
description | The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is reported to be a factor for good prognosis in some studies, while in others it is a factor for poor prognosis. The explanation for these different results could be linked to the fact that the studies were performed on different tumor types and with different therapy regimens. |
format | Online Article Text |
id | pubmed-3114547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31145472011-07-14 TP53 Status and Response to Treatment in Breast Cancers Varna, Mariana Bousquet, Guilhem Plassa, Louis-François Bertheau, Philippe Janin, Anne J Biomed Biotechnol Review Article The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is reported to be a factor for good prognosis in some studies, while in others it is a factor for poor prognosis. The explanation for these different results could be linked to the fact that the studies were performed on different tumor types and with different therapy regimens. Hindawi Publishing Corporation 2011 2011-05-09 /pmc/articles/PMC3114547/ /pubmed/21760703 http://dx.doi.org/10.1155/2011/284584 Text en Copyright © 2011 Mariana Varna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Varna, Mariana Bousquet, Guilhem Plassa, Louis-François Bertheau, Philippe Janin, Anne TP53 Status and Response to Treatment in Breast Cancers |
title | TP53 Status and Response to Treatment in Breast Cancers |
title_full | TP53 Status and Response to Treatment in Breast Cancers |
title_fullStr | TP53 Status and Response to Treatment in Breast Cancers |
title_full_unstemmed | TP53 Status and Response to Treatment in Breast Cancers |
title_short | TP53 Status and Response to Treatment in Breast Cancers |
title_sort | tp53 status and response to treatment in breast cancers |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114547/ https://www.ncbi.nlm.nih.gov/pubmed/21760703 http://dx.doi.org/10.1155/2011/284584 |
work_keys_str_mv | AT varnamariana tp53statusandresponsetotreatmentinbreastcancers AT bousquetguilhem tp53statusandresponsetotreatmentinbreastcancers AT plassalouisfrancois tp53statusandresponsetotreatmentinbreastcancers AT bertheauphilippe tp53statusandresponsetotreatmentinbreastcancers AT janinanne tp53statusandresponsetotreatmentinbreastcancers |